Not available
Quote | Axsome Therapeutics Inc. (NASDAQ:AXSM)
Last: | $65.72 |
---|---|
Change Percent: | 0.39% |
Open: | $69.44 |
Close: | $65.72 |
High: | $70.0775 |
Low: | $65.6065 |
Volume: | 834,137 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Axsome Therapeutics Inc. (NASDAQ:AXSM)
2024-04-16 13:17:12 ET Summary Intra-Cellular Therapies, Inc. achieved positive results from Study 501, using lumateperone as an adjunctive therapy for the treatment of patients with MDD; Both primary and secondary endpoints achieved with statistical significance. The Major Depres...
AXS-05 in Alzheimer’s disease agitation data featured in oral plenary session New data for AXS-07 in migraine demonstrating efficacy in pooled analysis Presentations on cognitive and wake promoting effects of solriamfetol NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) --...
Message Board Posts | Axsome Therapeutics Inc. (NASDAQ:AXSM)
Subject | By | Source | When |
---|---|---|---|
$AXSM Price now last trade up | Frankestin | investorshub | 06/27/2023 11:05:09 PM |
$AXSM best news of the day | MiamiGent | investorshub | 06/26/2023 5:43:47 AM |
New mid term topic $100.00 by or before | georgejjl | investorshub | 06/23/2023 4:29:46 PM |
$AXSM what do you make of this data? | georgejjl | investorshub | 06/23/2023 3:51:48 PM |
Their target has been reached. Now what? | rosemountbomber | investorshub | 06/23/2023 12:11:48 PM |
News, Short Squeeze, Breakout and More Instantly...
Axsome Therapeutics Inc. Company Name:
AXSM Stock Symbol:
NASDAQ Market:
Axsome Therapeutics Inc. Website:
AXS-05 in Alzheimer's disease agitation data featured in oral plenary session New data for AXS-07 in migraine demonstrating efficacy in poole...
AXS-05 in Alzheimer’s disease agitation data featured in oral plenary session New data for AXS-07 in migraine demonstrating efficacy in pooled analysis Presentations on cognitive and wake promoting effects of solriamfetol NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) --...
NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering nove...